RAD18 and uterine cervix carcinoma in situ: We designed a case-control study based on a large sample population, selecting 6 SNP loci from RAD18 and detecting their distribution in the peripheral blood cell genomes of 650 cases of CIN III, 580 cases of cervical squamous cell carcinoma (CSCC), and 1320 normal healthy controls.